tiprankstipranks
Atai Beckley N.V. (ATAI)
NASDAQ:ATAI
US Market
ATAI
Atai Beckley N.V.
RESEARCH TOOLSreports

Atai Beckley N.V. (ATAI) Stock News & Sentiment

2,071 Followers
ATAI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ATAI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
19d ago
ATAI
AtaiBeckley: Advancing BPL-003 Into Pivotal Phase 3 With Strategic Optionality and Strong Cash Runway Supporting a Buy Rating
Premium
Ratings
AtaiBeckley: Advancing BPL-003 Into Pivotal Phase 3 With Strategic Optionality and Strong Cash Runway Supporting a Buy Rating
24d ago
ATAI
Buy Rating on BPL-003 Underpinned by Strong Phase 2a Efficacy, De-Risked Phase 3 Program, and Upside to $25 Target Price
Premium
Ratings
Buy Rating on BPL-003 Underpinned by Strong Phase 2a Efficacy, De-Risked Phase 3 Program, and Upside to $25 Target Price
25d ago
ATAI
ATAI Life Sciences: Reiterating Buy on BPL-003’s Differentiated TRD Profile, Pricing Power, and Long-Dated IP Protection
Premium
Ratings
ATAI Life Sciences: Reiterating Buy on BPL-003’s Differentiated TRD Profile, Pricing Power, and Long-Dated IP Protection
1M ago
ATAI
Cathie Wood Leverages Baidu’s Post-Earnings Dip, Sells PagerDuty
Premium
Market News
Cathie Wood Leverages Baidu’s Post-Earnings Dip, Sells PagerDuty
1M ago
PD
ARKK
Buy Rating on ATAI Life Sciences Driven by Promising Phase 2a EMP-01 Efficacy and Differentiated Dosing in Social Anxiety Disorder
Premium
Ratings
Buy Rating on ATAI Life Sciences Driven by Promising Phase 2a EMP-01 Efficacy and Differentiated Dosing in Social Anxiety Disorder
1M ago
ATAI
ATAI Life Sciences: Advancing Psychedelic Pipeline Sets Up Data-Rich 2026 and Supports Reiterated Buy Rating
Premium
Ratings
ATAI Life Sciences: Advancing Psychedelic Pipeline Sets Up Data-Rich 2026 and Supports Reiterated Buy Rating
3M ago
ATAI
More ATAI News >

ATAI News on the Web

Psychedelic: AtaiBeckley reports publication of BPL-003 study results
TipRanks News
Neutral
AtaiBeckley reports rapid response in Phase 2a trial of depression drug BPL-003
Proactive Investors
Bullish
AtaiBeckley's BPL-003 Shows Rapid, Durable Antidepressant Response In TRD
rttnews
Neutral
AtaiBeckley announces peer-reviewed Phase 2a results of BPL-003 study
TipRanks News
Neutral
Analysts Are Bullish on These Healthcare Stocks: Atai Beckley N.V. (ATAI), MapLight Therapeutics, Inc. (MPLT)
TipRanks News
Bullish
Psychedelic therapies are becoming mainstream. Deutsche Bank thinks this drug developer could triple
CNBC
Neutral
AtaiBeckley awarded ‘Buy’ rating in initial coverage from Deutsche Bank analysts
Proactive Investors
Neutral
Here are Friday's biggest analyst calls: Nvidia, Apple, Tesla, Netflix, Disney, Alphabet, Tripadvisor & more
CNBC
Neutral

News Score - Last 7 Days

Positive
ATAI
Sector Average
Media Buzz
This Week5 articles
Weekly Average4.5 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ATAI’s Media Buzz Sentiment?
5 articles about ATAI were published this week. In an average week, 4.5 articles are published.
    What is ATAI’s weekly average amount of articles?
    In an average week, 4.5 articles about ATAI are published.
      What is ATAI’s News Sentiment?
      100% of articles about ATAI were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week